CA51621-2 - 0x0000000000006D92
Males & Females of Non-Childbearing Potential - English Only
Everest
* Stipend may pay up to reflected amount.
Start Date:
May 31, 2026 - 10:30am
End Date:
July 17, 2026 - 10:45am
Study Details
Study Number: CA51621
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $23,000.00
Study Criteria
Age: 18 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 68
Study Schedule
Schedule Type: Long Term
Study Length: 40 Night Stay & 1 Phone Call
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 5/26/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 5/26/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Sunday | 5/31/2026 10:30:00 AM | 7/10/2026 8:00:00 AM | 1 | Phoenix | |
| Phone participant | Friday | 7/17/2026 10:45:00 AM | 3 | Phoenix |
